Cahill Wealth Management, LLC Viking Therapeutics, Inc. Transaction History
Cahill Wealth Management, LLC
- $196 Million
- Q4 2024
A detailed history of Cahill Wealth Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cahill Wealth Management, LLC holds 15,295 shares of VKTX stock, worth $445,084. This represents 0.31% of its overall portfolio holdings.
Number of Shares
15,295
Previous 13,780
10.99%
Holding current value
$445,084
Previous $872,000
29.47%
% of portfolio
0.31%
Previous 0.45%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
467Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$296 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$175 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$143 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$75.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$62.8 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.23B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...